← Back to Search

Gallium Ga 68 PSMA-R2 for Prostate Adenocarcinoma

Phase 2
Waitlist Available
Research Sponsored by Andrei Iagaru
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 year post-scan follow-up
Awards & highlights

Summary

This trial studies how well two special imaging agents combined with PET/MRI scans work in detecting prostate cancer that has returned after initial treatment. It targets patients whose cancer has come back, using the agents to highlight cancer cells on the scans.

Eligible Conditions
  • Prostate Adenocarcinoma
  • Prostate-Specific Antigen
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 year post-scan follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 year post-scan follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Lesions Detected by Investigational Imaging Agent
Secondary study objectives
Number of Detected Lesions Confirmed to be Malignant for Each Imaging Method

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm II (Ga68 PSMA-R2 and Ga 68-NeoBOMB1)Experimental Treatment2 Interventions
Participants receive gallium Ga 68 PSMA-R2 IV and 45-60 minutes later undergo PET/MRI. Within 2 weeks, participants receive gallium Ga 68 DOTA-NeoBOMB1 IV then undergo PET/MRI 45 minutes later.
Group II: Arm I (Ga68-NeoBOMB1 and Ga68 PSMA-R2Experimental Treatment2 Interventions
Participants receive gallium Ga 68 DOTA-NeoBOMB1 IV and 45 minutes later, undergo PET/MRI. Within 2 weeks, participants receive gallium Ga 68 PSMA-R2 IV then undergo PET/MRI 45-60 minutes later.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gallium Ga 68 DOTA-NeoBOMB1
2020
Completed Phase 2
~30
Gallium Ga 68 PSMA-R2
2020
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

Andrei IagaruLead Sponsor
15 Previous Clinical Trials
569 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top